Controversy over AstraZeneca’s Covid-19 vaccine has sparked some investor concerns about its stock, according to Jefferies – but it’s not all bad news for the British pharmaceutical company. Australia, the Philippines and the African Union have become the latest to either curb or abandon planned purchases of the Oxford University-AstraZeneca coronavirus shot due to possible links to […] Read more
The British government and health experts in the country have rushed to defend the coronavirus vaccine developed by AstraZeneca and the University of Oxford following concerns over a possible link to blood clots. On Wednesday, the U.K.’s health and vaccine regulators issued a change of guidance over who should receive the shot. They now recommend that […] Read more
Europe’s medicines regulator found a possible link between the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues — though it said the benefits of getting the shot still outweigh its risks. Unusual blood clotting with low blood platelets will be added as a “very rare” side effect to the vaccine’s […] Read more
